{"id":66965,"date":"2025-04-23T12:01:57","date_gmt":"2025-04-23T12:01:57","guid":{"rendered":"https:\/\/english.saigonbiz.com.vn\/2025\/04\/23\/rectify-pharma-to-share-preclinical-data-highlighting-progress-in-hepatobiliary-program-at-easl-2025\/"},"modified":"2025-04-23T12:01:57","modified_gmt":"2025-04-23T12:01:57","slug":"rectify-pharma-to-share-preclinical-data-highlighting-progress-in-hepatobiliary-program-at-easl-2025","status":"publish","type":"post","link":"https:\/\/english.saigonbiz.com\/vn\/rectify-pharma-to-share-preclinical-data-highlighting-progress-in-hepatobiliary-program-at-easl-2025\/","title":{"rendered":"Rectify Pharma to Share Preclinical Data Highlighting Progress in Hepatobiliary Program at EASL 2025"},"content":{"rendered":"<div>\n<p align=\"left\">BOSTON, April  23, 2025  (GLOBE NEWSWIRE) &#8212; Rectify Pharmaceuticals, Inc., (\u201cRectify\u201d) a biotechnology company pioneering positive functional modulators (PFMs) that restore and enhance membrane protein function, today announced that it will present a preclinical abstract in an oral presentation at the upcoming European Association for the Study of the Liver 2025 Congress, taking place in Amsterdam, The Netherlands, May 7 \u2013 10, 2025.<\/p>\n<p>The data will showcase the potential of a novel ABCB4\/BSEP dual-targeting oral small molecule PFM to treat primary sclerosing cholangitis (PSC) and other hepatobiliary diseases.<\/p>\n<p><strong>Details for the oral presentation are as follows: <\/strong><\/p>\n<p><strong>Title:<\/strong> Novel dual-acting ABCB4\/MDR3 and ABCB11\/BSEP positive functional modulator demonstrates anti-cholestatic and anti-cholangitis activity in two orthogonal models of hepatobiliary disease<br \/><strong>Abstract Number:<\/strong> 842<br \/><strong>Presenter: <\/strong>Eric Bell, Ph.D.<br \/><strong>Session: <\/strong>Abstract Session &#8211;\u00a0Immune-mediated &amp; Cholestatic Diseases <br \/><strong>Date and Time<\/strong>: Friday, May 9, 2025, 8:30 a.m. \u2013 9:45 a.m. CEST<\/p>\n<p>The presentation will be made available on the Rectify <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=KEn-2O0Jk5rZP1UWuuuxfjGtUJZse9-kAsVERajOOkQ96XETnpJDrTe9-M7dJAZ0_malMTlBsNvdXmVS5G-dUaiaBsDYv2idW-UCtb-3A7c=\" rel=\"nofollow\" target=\"_blank\" title=\"website\">website<\/a> following the session.<\/p>\n<p><strong>About Rectify Pharmaceuticals, Inc. (\u201cRectify\u201d)<\/strong><\/p>\n<p>Rectify is advancing Positive Functional Modulators (PFMs), a novel class of oral, small molecules that restore and enhance membrane protein function to address the underlying cause of serious diseases. Rectify\u2019s PFMs have potential to modulate the activity of wild-type and mutated membrane bound proteins, a historically difficult challenge with a small molecule approach. The Company\u2019s breakthrough product platform enables efficient and rapid discovery of first- and best-in-class small molecule therapies with the potential to address membrane protein dysfunction for treatment of rare and common diseases, including liver, cardio-renal-metabolic, and neurodegenerative diseases. Rectify was founded and seeded by Atlas Venture who co-led the $100M Series A round with Omega Funds and were joined by Forbion and Longwood Fund.<\/p>\n<p>For more information, please visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=mtYU69X9VWAxw56M-mfAIzs0a5tEx3j5rUUmMTCNfuEcZWdL6Mr4hFrMvsVAkC3iogeBE-I9iiDO3Ypf1nA-6AVhTahTx9kRgnSKuL2IX-Q=\" rel=\"nofollow\" target=\"_blank\" title=\"www.rectifypharma.com\">www.rectifypharma.com<\/a> or follow us on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=UlzzP9sFUOKLwB7x6xehdQCqXInZBazCYeiNGXfNyL0mTUBB7Ci9B7SiSMbE5pFyvrg4lZmMQW6T9HkAqkOlsQ==\" rel=\"nofollow\" target=\"_blank\" title=\"X\">X<\/a> and <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=56SPzWsKEA8vVHlZ-ttFtnOHhNSr4N5UGrk4qgFgjwbBM0Smo3KANfeC5SvF3S4ggArYHE03ZqE0lg288tyOojGkThY94HUW_uargOFD194vmInQlDc4YVC15OQkM-_5\" rel=\"nofollow\" target=\"_blank\" title=\"LinkedIn\">LinkedIn<\/a>.<\/p>\n<p><strong>Contact<\/strong><\/p>\n<p><strong>Media<\/strong><br \/>Michael Rubenstein<br \/>LifeSci Communications<br \/>+1 646-386-1613<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=4P7k6bD3UP0LBUSxrHr3BnWb7PG-Vk3lR_BxLURPzZuT_J_oW0FQYMmAUz1XuXmpY3kMPCd936awqsMuy2FPXV-6qT2aKzfgx7wgqLsL6YZkI2um4chUm4mtDQN6xyrf\" rel=\"nofollow\" target=\"_blank\" title=\"mrubenstein@lifescicomms.com\">mrubenstein@lifescicomms.com<\/a><\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/MzUyNTE3NGUtZTIwOS00ODY4LWEzNmYtNDhjZmFhMGM0MjBjLTUwMDEyNjM4My0yMDI1LTA0LTIzLWVu\/tiny\/Rectify-Pharmaceuticals-Inc-.png\" referrerpolicy=\"no-referrer-when-downgrade\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>BOSTON, April 23, 2025 (GLOBE NEWSWIRE) &#8212; Rectify Pharmaceuticals, Inc., (\u201cRectify\u201d) a biotechnology company pioneering positive functional modulators (PFMs) that restore and enhance membrane protein function, today announced that it will present a preclinical abstract in an oral presentation at the upcoming European Association for the Study of the Liver 2025 Congress, taking place in [&#8230;]\n","protected":false},"author":1,"featured_media":66966,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-66965","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pr-newswire"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v21.6 (Yoast SEO v21.6) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Rectify Pharma to Share Preclinical Data Highlighting Progress in Hepatobiliary Program at EASL 2025 - Biz and Live in Saigon<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/english.saigonbiz.com\/vn\/rectify-pharma-to-share-preclinical-data-highlighting-progress-in-hepatobiliary-program-at-easl-2025\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Rectify Pharma to Share Preclinical Data Highlighting Progress in Hepatobiliary Program at EASL 2025\" \/>\n<meta property=\"og:description\" content=\"BOSTON, April 23, 2025 (GLOBE NEWSWIRE) &#8212; Rectify Pharmaceuticals, Inc., (\u201cRectify\u201d) a biotechnology company pioneering positive functional\" \/>\n<meta property=\"og:url\" content=\"https:\/\/english.saigonbiz.com\/vn\/rectify-pharma-to-share-preclinical-data-highlighting-progress-in-hepatobiliary-program-at-easl-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"Biz and Live in Saigon\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/SaigonbizGroup\" \/>\n<meta property=\"article:published_time\" content=\"2025-04-23T12:01:57+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2025\/04\/Rectify-Pharmaceuticals-Inc-.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1\" \/>\n\t<meta property=\"og:image:height\" content=\"1\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/rectify-pharma-to-share-preclinical-data-highlighting-progress-in-hepatobiliary-program-at-easl-2025\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/rectify-pharma-to-share-preclinical-data-highlighting-progress-in-hepatobiliary-program-at-easl-2025\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\"},\"headline\":\"Rectify Pharma to Share Preclinical Data Highlighting Progress in Hepatobiliary Program at EASL 2025\",\"datePublished\":\"2025-04-23T12:01:57+00:00\",\"dateModified\":\"2025-04-23T12:01:57+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/rectify-pharma-to-share-preclinical-data-highlighting-progress-in-hepatobiliary-program-at-easl-2025\/\"},\"wordCount\":313,\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"articleSection\":[\"Pr Newswire\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/rectify-pharma-to-share-preclinical-data-highlighting-progress-in-hepatobiliary-program-at-easl-2025\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/rectify-pharma-to-share-preclinical-data-highlighting-progress-in-hepatobiliary-program-at-easl-2025\/\",\"name\":\"Rectify Pharma to Share Preclinical Data Highlighting Progress in Hepatobiliary Program at EASL 2025 - Biz and Live in Saigon\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\"},\"datePublished\":\"2025-04-23T12:01:57+00:00\",\"dateModified\":\"2025-04-23T12:01:57+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/rectify-pharma-to-share-preclinical-data-highlighting-progress-in-hepatobiliary-program-at-easl-2025\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/english.saigonbiz.com\/vn\/rectify-pharma-to-share-preclinical-data-highlighting-progress-in-hepatobiliary-program-at-easl-2025\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/rectify-pharma-to-share-preclinical-data-highlighting-progress-in-hepatobiliary-program-at-easl-2025\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/english.saigonbiz.com\/vn\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Rectify Pharma to Share Preclinical Data Highlighting Progress in Hepatobiliary Program at EASL 2025\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"name\":\"Biz and Live in Saigon\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\",\"name\":\"SaigonBiz Media\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"width\":512,\"height\":512,\"caption\":\"SaigonBiz Media\"},\"image\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/SaigonbizGroup\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"caption\":\"admin\"},\"sameAs\":[\"https:\/\/english.saigonbiz.com\/vn\"],\"url\":\"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Rectify Pharma to Share Preclinical Data Highlighting Progress in Hepatobiliary Program at EASL 2025 - Biz and Live in Saigon","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/english.saigonbiz.com\/vn\/rectify-pharma-to-share-preclinical-data-highlighting-progress-in-hepatobiliary-program-at-easl-2025\/","og_locale":"en_US","og_type":"article","og_title":"Rectify Pharma to Share Preclinical Data Highlighting Progress in Hepatobiliary Program at EASL 2025","og_description":"BOSTON, April 23, 2025 (GLOBE NEWSWIRE) &#8212; Rectify Pharmaceuticals, Inc., (\u201cRectify\u201d) a biotechnology company pioneering positive functional","og_url":"https:\/\/english.saigonbiz.com\/vn\/rectify-pharma-to-share-preclinical-data-highlighting-progress-in-hepatobiliary-program-at-easl-2025\/","og_site_name":"Biz and Live in Saigon","article_publisher":"https:\/\/www.facebook.com\/SaigonbizGroup","article_published_time":"2025-04-23T12:01:57+00:00","og_image":[{"width":1,"height":1,"url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2025\/04\/Rectify-Pharmaceuticals-Inc-.png","type":"image\/png"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/english.saigonbiz.com\/vn\/rectify-pharma-to-share-preclinical-data-highlighting-progress-in-hepatobiliary-program-at-easl-2025\/#article","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/rectify-pharma-to-share-preclinical-data-highlighting-progress-in-hepatobiliary-program-at-easl-2025\/"},"author":{"name":"admin","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6"},"headline":"Rectify Pharma to Share Preclinical Data Highlighting Progress in Hepatobiliary Program at EASL 2025","datePublished":"2025-04-23T12:01:57+00:00","dateModified":"2025-04-23T12:01:57+00:00","mainEntityOfPage":{"@id":"https:\/\/english.saigonbiz.com\/vn\/rectify-pharma-to-share-preclinical-data-highlighting-progress-in-hepatobiliary-program-at-easl-2025\/"},"wordCount":313,"publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"articleSection":["Pr Newswire"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/english.saigonbiz.com\/vn\/rectify-pharma-to-share-preclinical-data-highlighting-progress-in-hepatobiliary-program-at-easl-2025\/","url":"https:\/\/english.saigonbiz.com\/vn\/rectify-pharma-to-share-preclinical-data-highlighting-progress-in-hepatobiliary-program-at-easl-2025\/","name":"Rectify Pharma to Share Preclinical Data Highlighting Progress in Hepatobiliary Program at EASL 2025 - Biz and Live in Saigon","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#website"},"datePublished":"2025-04-23T12:01:57+00:00","dateModified":"2025-04-23T12:01:57+00:00","breadcrumb":{"@id":"https:\/\/english.saigonbiz.com\/vn\/rectify-pharma-to-share-preclinical-data-highlighting-progress-in-hepatobiliary-program-at-easl-2025\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/english.saigonbiz.com\/vn\/rectify-pharma-to-share-preclinical-data-highlighting-progress-in-hepatobiliary-program-at-easl-2025\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/english.saigonbiz.com\/vn\/rectify-pharma-to-share-preclinical-data-highlighting-progress-in-hepatobiliary-program-at-easl-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/english.saigonbiz.com\/vn\/"},{"@type":"ListItem","position":2,"name":"Rectify Pharma to Share Preclinical Data Highlighting Progress in Hepatobiliary Program at EASL 2025"}]},{"@type":"WebSite","@id":"https:\/\/english.saigonbiz.com\/vn\/#website","url":"https:\/\/english.saigonbiz.com\/vn\/","name":"Biz and Live in Saigon","description":"","publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/english.saigonbiz.com\/vn\/#organization","name":"SaigonBiz Media","url":"https:\/\/english.saigonbiz.com\/vn\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","width":512,"height":512,"caption":"SaigonBiz Media"},"image":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/SaigonbizGroup"]},{"@type":"Person","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6","name":"admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","caption":"admin"},"sameAs":["https:\/\/english.saigonbiz.com\/vn"],"url":"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/66965","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/comments?post=66965"}],"version-history":[{"count":0,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/66965\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media\/66966"}],"wp:attachment":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media?parent=66965"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/categories?post=66965"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/tags?post=66965"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}